POUR, Luděk, Lucie KOVÁŘOVÁ, Tomáš BÜCHLER, Zdeněk ADAM, Miroslav PENKA, Jiří VORLÍČEK and Roman HÁJEK. Evaluation of HGF and Endostatin in the bone marrow of patients with multiple myeloma and the effect of peripheral blood admixture. Scripta medica. Brno: Masaryk University, Faculty of Medicine, 2009, vol. 82, No 2, p. 123-126. ISSN 1211-3395.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Evaluation of HGF and Endostatin in the bone marrow of patients with multiple myeloma and the effect of peripheral blood admixture
Name in Czech Stanovení HGF a endostatinu v kostní dřeni pacientů s mnohočetným myelomem a vliv příměsi periferní krve
Authors POUR, Luděk (203 Czech Republic, guarantor), Lucie KOVÁŘOVÁ (203 Czech Republic), Tomáš BÜCHLER (703 Slovakia), Zdeněk ADAM (203 Czech Republic), Miroslav PENKA (203 Czech Republic), Jiří VORLÍČEK (203 Czech Republic) and Roman HÁJEK (203 Czech Republic).
Edition Scripta medica, Brno, Masaryk University, Faculty of Medicine, 2009, 1211-3395.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/09:00035772
Organization unit Faculty of Medicine
Keywords (in Czech) mnohočetný myelom;endostatin; HGF
Keywords in English multiple myeloma;endostatin; HGF
Tags endostatin, HGF, multiple myeloma
Changed by Changed by: Mgr. Anna Potáčová, Ph.D., učo 44190. Changed: 29/6/2009 14:20.
Abstract
The aim of our study was to evaluate the concentration changes in the proangiogenic hepatocyte growth factor and antiangiogenic endostatin during the sampling of large bone marrow volumes in patients with multiple myeloma.
Abstract (in Czech)
Cílem studie bylo stanovit změny hladin proangiogenního hepatocytárního růstového faktoru a protiangiogenního endostatinu během odběru velkého objemu kostní dřeně u pacientů s mnohočetným myelomem.
Links
LC06027, research and development projectName: Univerzitní výzkumné centrum - Česká myelomová skupina (Acronym: LC MGUS)
Investor: Ministry of Education, Youth and Sports of the CR, University Research Centre - Czech Myeloma Group
MSM0021622434, plan (intention)Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií
Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies
NR9225, research and development projectName: Optimalizace léčby pacientů s mnohočetným myelomem v České republice
PrintDisplayed: 2/5/2024 15:59